59 studies found for:    Open Studies | "Pigmentation Disorders"
Show Display Options
Rank Status Study
1 Unknown  Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
Conditions: Surgical Wound;   Hypo-pigmented Skin
Intervention: Device: Momelan Technologies Epidermal Graft Harvesting System
2 Not yet recruiting Nevus Doctor Clinical Decision Support
Conditions: Nevus;   Melanoma
Intervention: Device: Nevus doctor program
3 Recruiting Use of Tamoxifen in Systemic Mastocytosis
Condition: Systemic Mastocytosis
Intervention:
4 Unknown  Punchgrafting Techniques for Vitiligo
Conditions: Non-segmental Vitiligo;   Segmental Vitiligo;   Piebaldism
Intervention: Procedure: punchgrafting
5 Recruiting Photocil (Topical) for the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Drug: Photocil for Vitiligo;   Other: Placebo - Sunscreen (SPF 2)
6 Recruiting Midostaurin in Indolent Systemic Mastocytosis
Condition: Indolent Systemic Mastocytosis
Intervention: Drug: Midostaurin,
7 Recruiting Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment
Conditions: Skin Pigmentation;   Skin Irritation
Intervention: Device: "Biocellulose Mask", Farhorm®"
8 Not yet recruiting Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
Condition: Vitiligo
Interventions: Procedure: Needling;   Drug: Triamcinolone
9 Recruiting Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Conditions: Aggressive Systemic Mastocytosis;   Mast Cell Leukemia;   Systemic Mastocytosis
Interventions: Drug: brentuximab vedotin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Other: questionnaire administration
10 Recruiting Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Drug: Triamcinolone Acetonide
11 Recruiting The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients
Condition: Mastocytosis
Intervention: Drug: injections
12 Recruiting Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
Condition: Vitiligo
Interventions: Drug: topical tacrolimus treatment;   Drug: topical pimecrolimus treatment;   Drug: local mometasone furoate treatment;   Drug: cold cream
13 Recruiting A Multicenter Trial of Non-cultured Epidermal Cellular Grafting Versus Hyaluronic Acid for Repigmenting Stable Leukoderma (Vitiligo and Piebaldism)
Conditions: Vitiligo;   Piebaldism
Interventions: Device: VITICELL;   Device: PLACEBO
14 Recruiting Evaluation of an Herbal-Based De-Pigmenting System
Conditions: Melasma;   Hyperpigmentation
Interventions: Other: Herbal depigmenting agent (Epionce);   Drug: Hydroquinone
15 Unknown  Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
Condition: Advanced Systemic Mastocytosis
Intervention: Drug: Cladribine and pegylated interpheron alpha-2a
16 Unknown  Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model
Condition: Vitiligo
Intervention: Procedure: foreskin from healthy adults
17 Recruiting The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer;   Peutz-Jeghers Syndrome;   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
Intervention: Drug: Human synthetic secretin
18 Recruiting Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Condition: Xeroderma Pigmentosum
Intervention:
19 Recruiting Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Biological: Outer-Root-Sheath Melanocytes Suspension;   Biological: Placebo
20 Unknown  Treatment and Complication of Bath PUVA in Vitiligo
Condition: Vitiligo
Intervention: Device: Bath PUVA

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years